1 Oct 2025

๐Ÿง Quantifying burden across borders: Japanese Encephalitis in APAC

2025-10-06T12:31:30+02:00October 1, 2025|Conferences, Other|

At todayโ€™s ISPOR Real-World Evidence Summit 2025 , Puneet Kaushik presented new insights into the economic burden of Japanese Encephalitis(JE) across Asia-Pacific.

๐Ÿ” Despite vaccines and treatments, JE continues to strain health systems through:
โ€ข High inpatient and ICU demands
โ€ข Significant productivity [โ€ฆ]

13 Aug 2025

๐Ÿ“ŠMultiple sclerosis, EBV & Nordic data recognised at ECTRIMS

2025-08-13T13:02:32+02:00August 13, 2025|All, Other|

Excited to share that our Danish-Swedish real-world study has been selected for the ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“ ๐๐ž๐ฌ๐ญ ๐จ๐Ÿ ๐„๐‚๐“๐‘๐ˆ๐Œ๐’ slide deck โ€“ highlighting it as one of this yearโ€™s top abstracts.

The abstract, co-authored by Jonas Banefelt and Mathias Lilja, explores the link [โ€ฆ]

30 Jun 2025

From 1 September 2025, companies must notify the DMP (NOMA) three months in advance before submitting STA documentation

2025-06-30T16:41:22+02:00June 30, 2025|All, Other|

See what else will change below ๐Ÿ‘‡

The DMP has published updated requirements for the single technology assessment (STA) submission process, applying to both reimbursement and hospital medicines, effective from 1 September 2025.

Key changes:
โ€ข ๐Ÿ—“ Companies must notify the DMP of [โ€ฆ]

Go to Top